Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.72M | 4.58M | 6.82M | 9.43M | 9.65M |
| Gross Profit | -3.72M | -4.58M | -6.82M | -9.43M | -9.65M |
| SG&A Expenses | 5.64M | 7.60M | 4.78M | 5.31M | 6.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.36M | 12.18M | 11.60M | 15.14M | 15.64M |
| Operating Income | -9.36M | -12.18M | -11.60M | -15.14M | -15.64M |
| Income Before Tax | -8.59M | -9.07M | -10.22M | -13.67M | -16.12M |
| Income Tax Expenses | 28.00K | 53.00K | 10.00K | 62.00K | 27.00K |
| Earnings from Continuing Operations | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.62M | -9.12M | -10.23M | -13.73M | -16.15M |
| EBIT | -9.36M | -12.18M | -11.60M | -15.14M | -15.64M |
| EBITDA | -9.27M | -12.09M | -11.51M | -15.05M | -15.43M |
| EPS Basic | -0.18 | -0.19 | -0.21 | -0.28 | -0.33 |
| Normalized Basic EPS | -0.09 | -0.11 | -0.12 | -0.17 | -0.18 |
| EPS Diluted | -0.18 | -0.19 | -0.21 | -0.28 | -0.33 |
| Normalized Diluted EPS | -0.09 | -0.11 | -0.12 | -0.17 | -0.18 |
| Average Basic Shares Outstanding | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M |
| Average Diluted Shares Outstanding | 48.26M | 48.26M | 48.26M | 48.26M | 48.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |